DanaherDHR +1.54%72 EV-to-FCF is 28.66 as of Jun. 27, 2026, which is 2% above its 10-year median of 28.01. GuruFocus rates DHR with a GF Score™ of 72/100 and a GF Value™ of $237.03 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 98 Medical Diagnostics & Research companies, Danaher ranks worse than 57.14% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Danaher's Enterprise Value is $151,649 Mil.
Danaher's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $5,291 Mil. Therefore, Danaher's EV-to-FCF for today is 28.66.
The historical rank and industry rank for Danaher's EV-to-FCF or its related term are showing as below:
DHR'
s EV-to-FCF Range Over the Past 10 Years
Min: 15.55 Med: 28.01 Max: 43.32
Current: 28.66
During the past 13 years, the highest EV-to-FCF of Danaher was 43.32. The lowest was 15.55. And the median was 28.01.
DHR's EV-to-FCF is ranked worse than 57.14% of 98
companies
in the Medical Diagnostics & Research industry
Industry Median: 22.585
vs DHR: 28.66
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Danaher's share price for today is $196.19.
Danaher's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.170.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Danaher EV-to-FCF Related Terms
Danaher EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Danaher's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Danaher's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Danaher EV-to-FCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Danaher's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Danaher's EV-to-FCF falls into.
Danaher's current Enterprise Value is $151,649 Mil.
Danaher's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,291 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Danaher (DHR) has a EV-to-FCF of 28.66 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Danaher and its competitors. This is near median its historical median of 28.01. Over the past decade, Danaher's EV-to-FCF has ranged from 15.55 to 43.32. According to the industry distribution chart, Danaher ranks #56 out of 98 companies in the Medical Diagnostics & Research industry, placing it in the top 57.1%.
Is Danaher's EV-to-FCF too high?
Danaher's current EV-to-FCF of 28.66 is near median its 10-year median of 28.01. Over the past 10 years, this metric has ranged from a low of 15.55 to a high of 43.32. The Medical Diagnostics & Research industry median EV-to-FCF is 22.59. Danaher's value of 28.66 is 26.9% above this industry median. Based on the distribution chart, Danaher ranks #56 out of 98 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Danaher has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Danaher's EV-to-FCF compare to TMO and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Danaher ranks #56 out of 98 companies for EV-to-FCF. This places Danaher in the lower half of its industry. The industry median EV-to-FCF is 22.59. Danaher's value of 28.66 is 26.9% above this benchmark. Historically, Danaher's own EV-to-FCF has ranged from 15.55 to 43.32 over the past decade. While the company's 10-year median is 28.01 vs. the industry median of 22.59, Danaher has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 22.59, based on 98 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Danaher's current EV-to-FCF of 28.66 is 26.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Danaher and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 22.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Danaher's current EV-to-FCF is 28.66, which is near median its own 10-year median of 28.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danaher stock overvalued right now?
Based on GuruFocus' analysis, Danaher (DHR) is currently considered Modestly Undervalued. The stock's GF Value™ is $237.03, compared to a current price of $196.19 — trading 17.2% below its estimated fair value. The current EV-to-FCF is 28.66, which is near median its 10-year median of 28.01 and 26.9% above the Medical Diagnostics & Research industry median of 22.59. Danaher's overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Danaher (DHR), the current EV-to-FCF is 28.66 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Danaher (DHR) Overvalued in 2026?
Based on GuruFocus' analysis, Danaher stock appears to be undervalued.
The current stock price of $196.19 is trading 17.2% below its estimated GF Value™ of $237.03.
GuruFocus considers Danaher to be Modestly Undervalued.
Key valuation signals for DHR:
EV-to-FCF: 28.66 (near median its 10-year median of 28.01)
GF Value™: $237.03 vs. price of $196.19 (17.2% below fair value)
Industry Position: 26.9% above the Medical Diagnostics & Research median (#56 of 98)
No single metric tells the full story. See the DHR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
72GF Score
Get the complete analysis for DHR
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHR has been successfully added to your 
